Conventional melanoma therapies, including chemotherapy and radiotherapy, suffer from the toxicity and side effects of repeated treatments due […]

Ilaris works by blocking the effects of IL-1 and suppressing inflammation in patients with this autoinflammatory disorder

The move follows data from the RECOVERY trial showing no beneficial effect of the drug in patients hospitalised […]

The deal gives GSK access to IDEAYA’s MAT2A, Pol Theta, and Werner Helicase programmes

The drug will be funded on the NHS to treat ulcerative colitis under certain conditions

The company is participating in LifeArc’s funding initiative for COVID-19 clinical trials

Novartis takes aim at Eli Lilly with Cosentyx FDA nod in spondyloarthritis kblankenship Tue, 06/16/2020 – 21:47

Updated Date: Tue, 09 Jun 2020 00:00:00 EDT

Updated Date: Tue, 09 Jun 2020 00:00:00 EDT

Updated Date: Tue, 09 Jun 2020 00:00:00 EDT